Literature DB >> 7574453

Paroxysmal dyskinesias: clinical features and classification.

M Demirkiran1, J Jankovic.   

Abstract

We studied 46 patients with paroxysmal dyskinesia and classified them according to phenomenology, duration of attacks, and etiology. There were 13 patients, 7 females, who had paroxysmal kinesigenic dyskinesia (PKD), 10 with attacks lasting 5 minutes or less (short lasting) and 3 with attacks lasting longer than 5 minutes (long lasting). Twenty-six patients, 18 females, had paroxysmal nonkinesigenic dyskinesia (PNKD), 9 with short-lasting and 17 with long-lasting PNKD. Five patients, 3 females, had paroxysmal exertion-induced dyskinesia (PED), 3 with short-lasting PED and the other 2 with long-lasting PED. In addition, there was 1 patient with paroxysmal hypnogenic dyskinesia (PHD) and 1 with paroxysmal superior oblique myokymia. Only 2 patients, 1 with PKD and 1 with PHD, had family history of paroxysmal dyskinesias. No specific cause could be identified in 21 patients; in the other 23 patients the etiologies included the following: psychogenic (9 patients), cerebrovascular diseases (4), multiple sclerosis (2), encephalitis (2), cerebral trauma (2), peripheral trauma (2), migraine (1), and kernicterus (1). Nine of 10 (90%) patients with PKD improved with medications, mostly anticonvulsants, compared with only 7 of 19 (37%) with PNKD. This new classification, based chiefly on precipitating events, allowed appropriate categorization of the attacks in all our patients with paroxysmal dyskinesias.

Entities:  

Mesh:

Year:  1995        PMID: 7574453     DOI: 10.1002/ana.410380405

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  89 in total

1.  ADCY5 mutation carriers display pleiotropic paroxysmal day and nighttime dyskinesias.

Authors:  Jennifer R Friedman; Aurélie Méneret; Dong-Hui Chen; Oriane Trouillard; Marie Vidailhet; Wendy H Raskind; Emmanuel Roze
Journal:  Mov Disord       Date:  2015-12-21       Impact factor: 10.338

2.  Diagnosis and treatment of paroxysmal dyskinesias revisited.

Authors:  Iris Unterberger; Eugen Trinka
Journal:  Ther Adv Neurol Disord       Date:  2008-09       Impact factor: 6.570

Review 3.  Diagnosis and management of acute movement disorders.

Authors:  D Dressler; R Benecke
Journal:  J Neurol       Date:  2005-10-10       Impact factor: 4.849

4.  Long-term improvement of paroxysmal dystonic choreathetosis with acetazolamide.

Authors:  Veronique Michel; Florence Riant; Elisabeth Tournier-Lasserve; Dominique Guehl; Alain Lagueny; Bernard Bioulac; Pierre Burbaud
Journal:  J Neurol       Date:  2006-04-28       Impact factor: 4.849

5.  A gene for familial paroxysmal dyskinesia (FPD1) maps to chromosome 2q.

Authors:  G T Fouad; S Servidei; S Durcan; E Bertini; L J Ptácek
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

6.  Deficit of striatal parvalbumin-reactive GABAergic interneurons and decreased basal ganglia output in a genetic rodent model of idiopathic paroxysmal dystonia.

Authors:  M Gernert; M Hamann; M Bennay; W Löscher; A Richter
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

7.  Severe familial paroxysmal exercise-induced dyskinesia.

Authors:  Pawel Tacik; Sebastian Loens; Christoph Schrader; Sabine Gayde-Stephan; Saskia Biskup; Dirk Dressler
Journal:  J Neurol       Date:  2014-08-07       Impact factor: 4.849

8.  Paroxysmal dyskinesias in mice.

Authors:  Thomas L Shirley; Lekha M Rao; Ellen J Hess; H A Jinnah
Journal:  Mov Disord       Date:  2008-01-30       Impact factor: 10.338

9.  Altered discharge pattern of basal ganglia output neurons in an animal model of idiopathic dystonia.

Authors:  Manuela Gernert; Mustapha Bennay; Maren Fedrowitz; Jan H Rehders; Angelika Richter
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

10.  Paroxysmal dyskinesias in the lethargic mouse mutant.

Authors:  Zubair Khan; H A Jinnah
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.